MacroGenics
MGNX
#9393
Rank
$86.66 M
Marketcap
$1.37
Share price
-0.72%
Change (1 day)
-59.59%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of September 2025 : $67 Million USD

According to MacroGenics's latest financial reports the company has $67 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$0.11 B-23.95%
2023-12-31$$0.15 B7.46%
2022-12-31$$0.14 B-40.73%
2021-12-31$$0.23 B-19.02%
2020-12-31$$0.29 B28.29%
2019-12-31$$0.23 B-5.04%
2018-12-31$$0.24 B-18.83%
2017-12-31$$0.29 B11.34%
2016-12-31$$0.26 B-14.23%
2015-12-31$$0.31 B158.35%
2014-12-31$$0.12 B53.69%
2013-12-31$$78.91 M-1058.01%
2012-12-31$-$8.24 Million-52.89%
2011-12-31$-$17.49 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Xencor
XNCR
$0.62 B 833.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$93.09 B 138,847.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$51.90 B 77,371.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$21.45 B 31,923.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.61 B 14,256.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$23.85 B 35,497.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$18.60 B 27,660.78%๐Ÿ‡บ๐Ÿ‡ธ USA